Previous Close | 5.25 |
Open | 5.44 |
Bid | 5.24 x 200 |
Ask | 5.34 x 200 |
Day's Range | 5.27 - 5.44 |
52 Week Range | 4.87 - 13.49 |
Volume | |
Avg. Volume | 99,736 |
Market Cap | 1.875B |
Beta (5Y Monthly) | 1.11 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.25 |
Earnings Date | May 22, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 12.80 |
BAYER AND EVOTEC UPDATE FOCUS OF THEIR COLLABORATION TO CARDIOVASCULAR DISEASES STRATEGIC ALLIANCE LEVERAGES HUMAN INDUCED PLURIPOTENT STEM CELL DISEASE MODELLING FOR IDENTIFICATION OF NOVEL TARGETS JOINT EFFORT AIMS TO DEVELOP INNOVATIVE THERAPIES ...
Evotec SE (NASDAQ:EVO) Q4 2023 Earnings Call Transcript April 24, 2024 Evotec SE misses on earnings expectations. Reported EPS is $-0.05 EPS, expectations were $-0.03333. Evotec SE isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Ladies and gentlemen, welcome to […]
One of the biggest stories of last week was how Evotec SE ( ETR:EVT ) shares plunged 32% in the week since its latest...